Gilead Sciences (GB:0QYQ)

Gilead Sciences (0QYQ) Income Statement


Gilead Sciences Income Statement

Last quarter (Q3 2023), Gilead Sciences's total revenue was $7.05B, an increase of 0.13% from the same quarter last year. In Q3, Gilead Sciences's net income was $2.18B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 27.31B$ 27.28B$ 27.01B$ 24.69B$ 22.45B$ 22.13B
Cost of Revenue
$ 5.80B$ 5.66B$ 6.60B$ 4.57B$ 4.67B$ 4.85B
Gross Profit
$ 21.59B$ 21.62B$ 20.70B$ 20.12B$ 17.77B$ 17.27B
Operating Expense
$ 10.47B$ -10.65B$ 10.79B$ 10.19B$ 8.44B$ 7.98B
Operating Income
$ 11.12B$ 10.97B$ 9.92B$ 9.93B$ 9.34B$ 9.30B
Net Non Operating Interest Income Expense
$ -1.09B$ -935.00M$ -1.64B$ -984.00M$ -995.00M$ -1.08B
Other Income Expense
$ -4.16B$ 4.22B$ -3.62B$ -7.27B$ -3.18B$ -422.00M
Pretax Income
$ 7.24B$ 5.81B$ 8.28B$ 1.67B$ 5.16B$ 7.80B
Tax Provision
$ 1.41B$ 1.25B$ 2.08B$ 1.58B$ -204.00M$ 2.34B
Earnings From Equity Interest Net Of Tax
$ -950.00M-$ 3.62B---
Net Income Common Stockholders
$ 5.88B$ 4.59B$ 6.22B$ 123.00M$ 5.39B$ 5.46B
Basic EPS
$ 4.71$ 3.66$ 4.96$ 0.10$ 4.24$ 4.20
Diluted EPS
$ 4.66$ 3.64$ 4.93$ 0.10$ 4.22$ 4.17
Basic Average Shares
$ 5.00B$ 1.25B$ 1.26B$ 1.26B$ 1.27B$ 1.30B
Diluted Average Shares
$ 5.04B$ 1.26B$ 1.26B$ 1.26B$ 1.28B$ 1.31B
Dividend Per Share
$ 2.98$ 2.92$ 2.84$ 2.72$ 2.52$ 2.28
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
---$ 7.09$ 6.63$ 6.67
Rent Expense Supplemental
Total Expenses
$ 16.27B$ 17.25B$ 17.39B$ 14.76B$ 13.11B$ 12.83B
Net Income From Continuing And Discontinued Operation
$ 5.88B$ 4.59B$ 6.22B$ 123.00M$ 5.39B$ 5.46B
Normalized Income
$ 7.02B$ 3.65B-$ 4.40B$ 9.07B$ 6.22B
Interest Expense
$ 226.00M--$ 984.00M$ 995.00M$ 1.08B
$ 8.15B$ 6.75B$ 9.28B$ 2.65B$ 6.16B$ 8.88B
$ 10.69B$ 8.85B$ 11.33B$ 4.13B$ 7.56B$ 10.30B
Currency in USD

Gilead Sciences Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis